| Name | GSK-626616 |
|---|---|
| Synonyms |
GSK-626616, 10 mM in DMSO
GSK 626616,DYRK,Inhibitor,Dual specificity tyrosine regulated kinase,GSK-626616,GSK626616,inhibit,Dual specificity tyrosine phosphorylation regulated kinase 4(5H)-Thiazolone, 2-[(2,6-dichlorophenyl)amino]-5-(6-quinoxalinylmethylene)-, (5Z) OKY0RM282V (5Z)-2-[(2,6-Dichlorophenyl)amino]-5-(6-quinoxalinylmethylene)-1,3-thiazol-4(5H)-one GSK 626616 - Bio-X (Z)-2-((2,6-Dichlorophenyl)amino)-5-(quinoxalin-6-ylmethylene)thiazol-4(5H)-one (5Z)-2-[(2,6-Dichlorophenyl)amino]-5-(6-quinoxalinylmethylene)-4(5H)-thiazolone |
| Description | GSK-626616 is a potent, orally bioavailable inhibitor of DYRK3 (IC50=0.7 nM). GSK-626616 inhibits other members of the DYRK family (e.g., DYRK1A and DYRK2) with similar potency, which is a potential therapy for the treatment of anemia[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 0.7 nM (DYRK3)[1] |
| References |
| Density | 1.6±0.1 g/cm3 |
|---|---|
| Boiling Point | 574.8±60.0 °C at 760 mmHg |
| Molecular Formula | C18H10Cl2N4OS |
| Molecular Weight | 401.269 |
| Flash Point | 301.4±32.9 °C |
| Exact Mass | 399.995239 |
| LogP | 4.16 |
| Vapour Pressure | 0.0±1.6 mmHg at 25°C |
| Index of Refraction | 1.755 |
| Storage condition | 2-8°C |